Immunohistochemical expression of PTEN and β-catenin for endometrial intraepithelial neoplasia in Japanese women

Annals of Diagnostic Pathology

Volumn 11, Issue 2, 2007, Pages 103-108

  Norimatsu, Yoshiaki ^a,f   Moriya, Takuya ^b   Kobayashi, Tadao K ^c   Sakurai, Takaki ^d   Shimizu, Keiko ^e   Tsukayama, Choutatsu ^a   Ohno, Eiji ^f  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Medical Care Center   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

^e Utsunomiya Hospital   (Japan)

^f KURASHIKI UNIVERSITY OF SCIENCE AND THE ARTS   (Japan)

Author keywords

catenin expression; Endometrial intraepithelial neoplasia; Immunohistochemistry; Japanese women; Mutation; PTEN

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; ESTROGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM TUMOR; EPITHELIUM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE; NULL ALLELE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RELIABILITY; STATISTICAL SIGNIFICANCE; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS;

ADULT; AGED; BETA CATENIN; CARCINOMA IN SITU; CELL NUCLEUS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; JAPAN; MIDDLE AGED; PREMENOPAUSE; PTEN PHOSPHOHYDROLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 33847383238     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2006.06.009     Document Type: Article

References (31)

1. Ronnett B.M., Zaino R.J., Ellenson L.H., and Kurman R.J. Endometrial carcinoma. In: Kurman R.J. (Ed). Blaustein's pathology of the female genital tract. 5th ed (2001), Springer-Verlag, New York 501-559
2. Silverberg S.G., Sasano N., and Yajima A. Endometrial carcinoma in Miyagi Prefecture, Japan: histopathologic analysis of a cancer registry based series and comparison with cases in American women. Cancer 49 (1982) 1504-1510
3. Sherman M.E., Sturgeon S., Brinton L., and Kurman R.J. Endometrial cancer chemoprevention: implications of diverse pathways of carcinogenesis. J Cell Biochem Suppl 23 (1995) 160-164
4. Tashiro H., Blazes M.S., Wu R., et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57 (1997) 3935-3940
5. Kong D., Suzuki A., Zou T.T., et al. PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet 17 (1997) 143-144
6. Risinger J.I., Hayes A.K., Berchuck A., and Barrett J.C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57 (1997) 4736-4738
7. Fukuchi T., Sakamoto M., Tsuda H., et al. Beta-catenin mutations in carcinoma of the uterine endometrium. Cancer Res 58 (1998) 3526-3528
8. Kobayashi K., Sagae S., Nishioka Y., et al. Mutations of the beta-catenin gene in endometrial carcinomas. Jpn J Cancer Res 90 (1999) 55-59
9. Mirabelli-Primdahl L., Gryfe R., Kim H., et al. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res 59 (1999) 3346-3351
10. Silverberg S.G., Kurman R.J., Nogales F., et al. Epithelial tumors and related lesions of endometrium. In: Tavassoli F.A., and Stratton M.R. (Eds). Tumors of the breast and female genital organs (2003), IARC Press, Lyon 221-232
11. Kurman R., Kaminski P., and Norris H. The behavior of endometrial hyperplasia: a long term study of "untreated" hyperplasia in 170 patients. Cancer 56 (1985) 403-412
12. Levine R.L., Cargile C.B., Blazes M.S., et al. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res 58 (1998) 3254-3258
13. Maxwell G.L., Risinger J.I., Gumbs C., et al. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res 58 (1998) 2500-2503
14. Moreno-Bueno G., Hardisson D., Sarrio D., et al. Abnormalities of e- and p-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia. J Pathol 199 (2003) 471-478
15. Saegusa M., Hashimura M., Yoshida T., and Okayasu I. Beta-catenin mutations and aberrant nuclear expression during endometrial tumorigenesis. Br J Cancer 84 (2001) 209-217
16. Kendall B.S., Ronnett B.M., Isacson C., et al. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 22 (1998) 1012-1019
17. Bergeron C., Nogales F.F., Masseroli M., et al. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol 23 (1999) 1102-1108
18. Mutter G.L. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol 76 (2000) 287-290
19. Mutter G.L. Histopathology of genetically defined endometrial precancers. Int J Gynecol Pathol 19 (2000) 301-309
20. Hecht J.L., Ince T.A., Baak J.P., et al. Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis. Mod Pathol 18 (2005) 324-330
21. Mutter G.L. Diagnosis of premalignant endometrial disease. J Clin Pathol 55 (2002) 326-331
22. Mutter G.L., Lin M.C., Fitzgerald J.T., et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92 (2000) 924-930
23. Mutter G.L., Ince T.A., Baak J.PA., et al. Molecular identification of latent precancers in histologically normal endometrium. Cancer Res 61 (2001) 4311-4314
24. Mutter G.L., Lin M.C., Fitzgerald J.T., et al. Changes in endometrial PTEN expression throughout the human menstrual cycle. J Clin Endocrinol Metab 85 (2000) 2334-2338
25. Kanamori Y., Kigawa J., Itamochi H., et al. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Clin Cancer Res 7 (2001) 892-895
26. Kimura F., Watanabe J., Hata H., et al. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus. J Cancer Res Clin Oncol 130 (2004) 161-168
27. Kaku T., Silverberg S.G., Tsukamoto N., et al. Association of endometrial epithelial metaplasias with endometrial carcinoma and hyperplasia in Japanese and American women. Int J Gynecol Pathol 12 (1993) 297-300
28. Kanaya T., Kyo S., Sakaguchi J., et al. Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population. Am J Clin Pathol 124 (2005) 89-96
29. Nei H., Saito T., Yamasaki H., et al. Nuclear localization of beta-catenin in normal and carcinogenic endometrium. Mol Carcinog 25 (1999) 207-218
30. Matias-Guiu X., Catasus L., Bussaglia E., et al. Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol 32 (2001) 569-577
31. Wappenschmidt B., Wardelmann E., Gehrig A., et al. PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas. Hum Pathol 35 (2004) 1260-1265